KR950703335A - 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents) - Google Patents

항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents) Download PDF

Info

Publication number
KR950703335A
KR950703335A KR1019950701292A KR19950701292A KR950703335A KR 950703335 A KR950703335 A KR 950703335A KR 1019950701292 A KR1019950701292 A KR 1019950701292A KR 19950701292 A KR19950701292 A KR 19950701292A KR 950703335 A KR950703335 A KR 950703335A
Authority
KR
South Korea
Prior art keywords
compound
bis
ethylamino
propyl
phenyl
Prior art date
Application number
KR1019950701292A
Other languages
English (en)
Inventor
에이. 스탠리 팀스
로널드 디. 스나이더
테리 엘. 보울린
Original Assignee
게리 디. 스트리트
메렐 다우 파마슈티칼스 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게리 디. 스트리트, 메렐 다우 파마슈티칼스 인크 filed Critical 게리 디. 스트리트
Publication of KR950703335A publication Critical patent/KR950703335A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14—Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

본 발명은 하기식(Ⅰ)의 폴리아민 화합물로 CMV 감염을 치료하는 거세 관한 것이다.
상기 식에서, Z1은 포화 또는 분지쇄(C2-C6) 알킬렌 잔기이고, m은 7또는 8이며, R기는 각각 독립적으로 수소, C1-C6포화 또는 블록화 히드로카 빌, 또는 -(CH2)x-(Ar)-X[여기서, Ar는 페닐 도는 나프틸이고, X는 H, C1-C6알콕시, 할로겐, C1-C4알킬이며, x는 정수 0, 1 또는 2임]이고, 단 R기는 둘다 수소일 수 없다. 식(Ⅰ)의 화합물의 그의 약제학적으로 허용 가능한 산부가염일 수 있다.

Description

항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivative as Anti-Cytomegaloviral Agents)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 항비루스 유효량의 하기식의 화합물 또는 그의 약제학적으로 허용 가능한 산부가염을 시토메갈로비루스 감염 억제를 필요로 하는 환자에게 투여하는 것으로 이루어지는 시토메갈로비루스 감염의 억제방법.
    상기 식에서 Z1은 분지쇄(C2-C6)알킬렌 잔기이고, m은 7 또는 8이며, R기는 각각 독립적으로 수소, C1-C6포화 또는 불포화 히드로카르빌, 또는 -(CH2)x-(Ar)-X[여기서, Ar는 페닐 또는 나프틸이고, X는 H, C1-C6알킬이며, x는 정수 0, 1 또는 2임]이고, 단, R기는 둘다 수소일 수 없다.
  2. 제1항에 있어서, N,N1-비스(3-(에틸아미노)프로필)-1,8-옥탄디민인 화합물.
  3. 제1항에 있어서, 1,18-비스[(페닐)메틸]1,5,14,18-테트라아자옥타데칸인 화합물.
  4. 제6항에 있어서, N,N1-비스(3-(에틸아미노)프로필)-1,7-헵탄디아민인 화합물.
  5. 제6항에 있어서, N,N1-비스[3-(에틸아미노)프로필]-1,7-디아미노헵탄인 화합물.
  6. 제4항에 있어서, 부가 성분으로써 유효량이 폴리아민 옥시다제 억제제를 추가로 함유하는 약제학적 조성물.
  7. 치료유효량의 하기식의 화합물 또는 그의 약제학적으로 허용 가능한 산부가염을 CMV 질환 치료를 필요로 하는 환자에게 투여하는 것으로 이루어지는 CMV 질병 상태로 고생하는 환자의 치료방법.
    상기 식에서 Z2은 포화쇄(C2-C6)알킬렌 잔기이고, m은 7 또는 8이며, R기는 각각 독립적으로 수소, C1-C6포화 또는 불포화 히드로카르빌, 또는 -(CH2)x-(Ar)-X[여기서, Ar는 페닐 또는 나프틸이고, X는 H, C1-C6알콕시, 할로겐, C1-C4알킬이며, x는 정수 0, 1 또는 2임]이고, 단, R기는 둘다 수소일 수 없다.
  8. 제1항에 있어서, N,N1-비스(3-(에틸아미노)프로필)-1,8-옥탄디아민인 화합물.
  9. 제1항에 있어서, 1,18-비스[(페닐)메틸]1,5,14,18-테트라아자옥타데칸인 화합물.
  10. 제6항에 있어서, N,N1-비스(3-(에틸아미노)프로필)-1,7-헵탄디아민인 화합물.
  11. 제6항에 있어서, N,N1-비스[3-(에틸아미노)프로필]-1,7-디아미노헵탄인 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950701292A 1992-10-05 1993-09-10 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents) KR950703335A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929220921A GB9220921D0 (en) 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents
GB9220921.2 1992-10-05
PCT/US1993/008517 WO1994007480A1 (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents

Publications (1)

Publication Number Publication Date
KR950703335A true KR950703335A (ko) 1995-09-20

Family

ID=10722983

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701292A KR950703335A (ko) 1992-10-05 1993-09-10 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents)

Country Status (9)

Country Link
EP (1) EP0662829A1 (ko)
JP (1) JPH08512279A (ko)
KR (1) KR950703335A (ko)
AU (1) AU4854793A (ko)
CA (1) CA2146319A1 (ko)
GB (1) GB9220921D0 (ko)
HU (1) HUT72663A (ko)
NZ (1) NZ256254A (ko)
WO (1) WO1994007480A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831001A (en) * 1990-10-24 1998-11-03 Allelix Biopharmaceuticals Inc. Treatment of herpesvirus infection
WO1995009832A1 (en) * 1993-10-07 1995-04-13 Merrell Dow Pharmaceuticals Inc. Novel process for preparing polyamine derivatives and intermediates thereof
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
US7045550B2 (en) 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
CA2463771A1 (en) 2001-10-16 2003-04-24 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
WO2019152373A1 (en) * 2018-01-30 2019-08-08 Sun Biopharma, Inc. Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU628174B2 (en) * 1989-05-23 1992-09-10 Merrell Dow Pharmaceuticals Inc. A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
EP0662829A1 (en) 1995-07-19
AU4854793A (en) 1994-04-26
HU9500982D0 (en) 1995-06-28
CA2146319A1 (en) 1994-04-14
JPH08512279A (ja) 1996-12-24
NZ256254A (en) 1997-04-24
GB9220921D0 (en) 1992-11-18
HUT72663A (en) 1996-05-28
WO1994007480A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
KR940005633A (ko) 약제학적으로 유용한 항경련제 설파메이트의 이미데이트 유도체
KR910015575A (ko) 1H-이미다조[4,5-c]퀴놀린-4-아민
KR930003912A (ko) 울혈성 심장 마비 치료법
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
KR950010892A (ko) 자궁 섬유증 억제 방법
ES2105286T3 (es) Derivados de etanolamina que tienen actividades simpatomimetica y anti-polaquiuria.
RU95117068A (ru) Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений
KR950016723A (ko) 자가면역 질병의 억제 방법
KR890006624A (ko) 디데옥시시티딘 유도체
RU2000123169A (ru) Бензотиадиазолы и их производные
RU2003134629A (ru) Соединения цефема
KR910004191A (ko) 신질환치료제
KR950703335A (ko) 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents)
KR900003105A (ko) N-2,3-부타디엔일 트리- 및 테트라아미노알칸 유도체
ATE103585T1 (de) Polyamin-derivate als antineoplastische wirkstoffe.
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
RU96103685A (ru) 1,2,5-тиадиазольные производные индолилалкил-пиридинил- и пиримидинил-пиперазинов, способ лечения или предотвращения развития сосудистой головной боли и фармацевтическая композиция
FI923759A0 (fi) Terapeutiska bensazapinfoereningar.
KR960034200A (ko) 항편두통성 인돌릴알킬-피리딘일 및 피리미딘일피페라진의 1,2,5-티아디아졸 유도체
KR950016753A (ko) 벤조[쥐(g)]퀴놀린의 신규의 사용 방법
OA08972A (fr) Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent
DE60124117D1 (de) Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
KR970706825A (ko) 헬리코박터의 감염에 기인하는 질환의 치료제(remedy for diseases caused by infection with helicobacter)
KR910018341A (ko) 신규 α-만노시다제 및 푸코시다제 억제제
WO1994007480B1 (en) Polyamine derivatives as anti-cytomegaloviral agents

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid